Stocks Cheers on Upbeat Move: Aetna Inc. (NYSE:AET), Hemispherx Biopharma, Inc. (NYSEMKT:HEB), Bristol-Myers Squibb Company (NYSE:BMY)

Aetna Inc. (NYSE:AET) released that that it has signed into a contract to purchase privately held bswift, which provides a technology platform that proposes a retail shopping experience for health insurance exchanges and employers nationwide. Shares of Aetna Inc. (NYSE:AET) opened at $82.78 with 351.70 million outstanding shares and hit to its highest price of $83.50 during the day and finally closed at $82.25 by scoring -0.32%. In the whole session, it traded on volume of 1.96 Million shares, which turned higher than its average volume.Hemispherx Biopharma, Inc. (NYSEMKT:HEB) released that it has been informed has been informed by USAMRIID scientists that they have in-vitro data indicating that Alferon, the only multi-species, natural alpha interferon ommercially permitted in the U.S., successfully protected human cells against the Ebola virus. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) stock hit highest price at $0.315, beginning with a price of $0.30 to the closed at 0.30 by an increase of 3.52% with a day range of $0.2928-$0.315. The total market capitalization remained 57.0 Million, total volume of 3.1 Million shares held in the session was surprisingly higher than its average volume of 1786.80 shares.Bristol-Myers Squibb Company (NYSE:BMY) and Galecto Biotech AB reported that the companies, together with the Galecto shareholders, have entered into an agreement that provides Bristol-Myers Squibb the exclusive option to acquire Galecto Biotech AB and gain worldwide rights to its lead asset TD139, a novel inhaled inhibitor of galectin-3 in Phase 1 development for the treatment of idiopathic pulmonary fibrosis and other pulmonary fibrotic conditions. On the other consideration, Bristol-Myers Squibb Company (NYSE:BMY) begun last trade with a price of $58.31 and throughout the trading session climbed at $58.77. The day-trade ended with a decrease of -0.67% to closed at $57.80. The stock is going forward its fifty-two week low with 26.66% and lagging behind from its 52 week high price with -2.08%. BMY last month stock price volatility remained 2.40%.